1
项与 Non-alcoholic fatty liver disease agent (University of California Irvine) 相关的临床试验Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD
The changes in liver function, body mass index, controlled attenuation parameters, liver stiffness and HBV-DNA at different time points in each group before and after treatment were counted to explore the clinical efficacy of Ganshuang granules combined with tenofovir in the treatment of CHB complicated with NAFLD.
100 项与 Non-alcoholic fatty liver disease agent (University of California Irvine) 相关的专利(医药)